Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tevogen Inc.

NASDAQ: TVGN · Life Sciences · 5 alerts · CIK 1860871

Share price
$6.22Close, Nov 16
Market cap
$40.5M
Shares outstanding
6.51MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tevogen Inc. filings on SEC EDGAR ↗

5:13 PM ET 8-K
Stock Plan Amendment

Tevogen Stock Plan Amendment

Tevogen Inc. granted performance-based restricted stock awards to its CEO Ryan Saadi (8,000,000 shares) and CFO Kirti Desai (750,000 shares) under the 2024 Omnibus Incentive Plan. Vesting is contingent upon the company achieving a $1.0 billion aggregate revenue threshold by September 30, 2031. The grants are intended to align executive compensation with long-term growth and stockholder value creation.

Term
through Sep 2031

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.